» Articles » PMID: 36682313

Sex and Pubertal Influences on the Neurodevelopmental Underpinnings of Schizophrenia: A Case for Longitudinal Research on Adolescents

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2023 Jan 22
PMID 36682313
Authors
Affiliations
Soon will be listed here.
Abstract

Sex is a significant source of heterogeneity in schizophrenia, with more negative symptoms in males and more affective symptoms and internalizing comorbidity in females. In this narrative review, we argue that there are likely sex differences in the pathophysiological mechanisms of schizophrenia-spectrum disorders (SZ) that originate during puberty and relate to the sex-specific impacts of pubertal maturation on brain development. Pubertal maturation might also trigger underlying (genetic or other) vulnerabilities in at-risk individuals, influencing brain development trajectories that contribute to the emergence of SZ. This review is the first to integrate links between pubertal development and neural development with cognitive neuroscience research in SZ to form and evaluate these hypotheses, with a focus on the frontal-striatal and frontal-limbic networks and their hypothesized contribution to negative and mood symptoms respectively. To test these hypotheses, longitudinal research with human adolescents is needed that examines the role of sex and pubertal development using large cohorts or high risk samples. We provide recommendations for such studies, which will integrate the fields of psychiatry, developmental cognitive neuroscience, and developmental endocrinology towards a more nuanced understanding of the role of pubertal factors in the hypothesized sex-specific pathophysiological mechanisms of schizophrenia.

Citing Articles

Nicotine's Effects on Schizophrenia-like Symptoms in a Mice Model: Time Matters.

Dutra-Tavares A, Couto L, Souza T, Bandeira-Martins A, Silva J, Filgueiras C Brain Sci. 2024; 14(9).

PMID: 39335351 PMC: 11430416. DOI: 10.3390/brainsci14090855.


In-Hospital Use of Long-Acting Injectable Antipsychotics and Readmission Risk in Patients With First-Admission Schizophrenia in Taiwan.

Chen W, Wu C, Liu C, Kuo P, Chan H, Lin Y JAMA Netw Open. 2024; 7(6):e2417006.

PMID: 38884998 PMC: 11184458. DOI: 10.1001/jamanetworkopen.2024.17006.


A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia.

Selvan P, Devkare P, Shetty A, Dharmadhikari S, Khandhedia C, Mane A Front Psychiatry. 2024; 15:1385925.

PMID: 38711874 PMC: 11071166. DOI: 10.3389/fpsyt.2024.1385925.


The social determinants of mental health and disorder: evidence, prevention and recommendations.

Kirkbride J, Anglin D, Colman I, Dykxhoorn J, Jones P, Patalay P World Psychiatry. 2024; 23(1):58-90.

PMID: 38214615 PMC: 10786006. DOI: 10.1002/wps.21160.


Immune System and Brain/Intestinal Barrier Functions in Psychiatric Diseases: Is Sphingosine-1-Phosphate at the Helm?.

Martin-Hernandez D, Munoz-Lopez M, Tendilla-Beltran H, Caso J, Garcia-Bueno B, Menchen L Int J Mol Sci. 2023; 24(16).

PMID: 37628815 PMC: 10454107. DOI: 10.3390/ijms241612634.


References
1.
Barendse M, Simmons J, Patton G, Mundy L, Byrne M, Seal M . Adrenarcheal Timing Longitudinally Predicts Anxiety Symptoms via Amygdala Connectivity During Emotion Processing. J Am Acad Child Adolesc Psychiatry. 2019; 59(6):739-748.e2. DOI: 10.1016/j.jaac.2019.04.018. View

2.
Bishop S, Duncan J, Brett M, Lawrence A . Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nat Neurosci. 2004; 7(2):184-8. DOI: 10.1038/nn1173. View

3.
Shirtcliff E, Allison A, Armstrong J, Slattery M, Kalin N, Essex M . Longitudinal stability and developmental properties of salivary cortisol levels and circadian rhythms from childhood to adolescence. Dev Psychobiol. 2011; 54(5):493-502. PMC: 3270212. DOI: 10.1002/dev.20607. View

4.
Ruiz A, Blanco R, Santander J, Miranda E . Relationship between sex differences in onset of schizophrenia and puberty. J Psychiatr Res. 2000; 34(4-5):349-53. DOI: 10.1016/s0022-3956(00)00030-3. View

5.
Cosoff S, Hafner R . The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder. Aust N Z J Psychiatry. 1998; 32(1):67-72. DOI: 10.3109/00048679809062708. View